Facebook Twitter RSS Feed

You are here

Coronary Intervention & Surgery

 - PCI

Active and real-time is better, especially when assessing device safety in the general population. A Massachussetts-based hospital network analyzing the safety of PCI-related devices found that a real-time safety alert was able to change practices to improve patient safety and outcomes.

 - heart

Surgeons using a nonsternotomy approach to replace continuous flow left ventricular assist devices (LVADs) found patients had better survival, according to a study published online Dec. 10 in Annals of Thoracic Surgery.

 - health_costs

Some things don’t make decisions easier: PCI may be more cost-effective, but CABG has fewer long-term major adverse events, according to a study published in the Dec. 1 issue of Catheterization and Cardiovascular Interventions.

 - ambulance, EMS

When every minute counts, delaying treatment can have enormous repercussions. An analysis of U.S. data finds that while door-to-balloon times have improved, many patients may still not receive care within the recommended 120 minutes, due in part to transfers to STEMI care centers.

 - Stent

A biodegradable drug-eluting stent (DES) proved to be noninferior to durable-polymer DES and both showed benefits over bare-metal stents (BMS) in the BASKET-PROVE II clinical trial. The results published online Nov. 19 in Circulation also raise questions about triggers for late complications.

 

More Stories

Two 2nd-gen drug-eluting stents equally safe, effective at 3 years

Three-year outcomes post-stenting reveal favorable and similar results for patients with and without bifurcated lesions treated with second-generation drug-eluting stents. 

Shunning FFR, most physicians choose to eyeball angiography results

Most cardiologists who participated in an international web survey used angiography results to assess intermediate stenoses over requesting fractional flow reserve (FFR) measurements or other techniques, contrary to guidelines. This was the case even when resources were not an obstacle.

Cardiologist dies in plane crash near Chicago

A small plane crash outside Chicago claimed the lives of three physicians Oct. 12, including a cardiologist from Kansas.

Ischemia differs in men, women under mental stress

At the heart of things, men and women do react differently to stress. According to a study published in the Oct. 21 issue of the Journal of the American College of Cardiology, the physical impact of mental and emotional stress on the heart and its function differs between men and women.

Almost half of 30-day readmissions post-PCI deemed preventable

Readmission rates following PCI could be nearly halved, according to research published online Sept. 26 in the Journal of the American Heart Association. The key, researchers wrote, starts with changing clinician behaviors.  

Liberal glucose control proves effective in reducing CABG mortality

In coronary artery bypass surgery (CABG), glucose control has shown to be important for survival. One research team, however, has questioned whether a strict or liberal glucose strategy was as effective or superior for improving survival. 

Unbalanced: Women die more often after STEMI PCI

Women are almost twice as likely as men to die of any cause in hospital after a STEMI-related primary PCI, according to a study published online Sept. 29 in JAMA: Internal Medicine. This disparity occurs in spite of increased awareness of modifiable risks, researchers wrote.

ACC takes revascularization off its ‘beware’ list

The American College of Cardiology (ACC) revised its Choosing Wisely list, removing a recommendation that questioned the necessity of coronary interventions that extend beyond revascularization of a culprit lesion.

Rates of stroke following acute MI drop as treatments improve

Risk of ischemic stroke within one year of acute MI dropped by 20 percent over a 10-year span in the general Swedish population in a study published online Sept. 18 in Stroke.

CABG raises quality of life in patients with ischemic left ventricular dysfunction

When treated for ischemic left ventricular dysfunction, patients who underwent CABG reported better quality-of-life compared with guideline therapy patients at different time points throughout follow-up of nearly five years. The CABG group also had lower depression scores.

Risks higher for women undergoing STEMI PCI

When treating ST-segment elevation myocardial infarction (STEMI) with percutaneous coronary intervention (PCI), does the patient’s sex have a role in their outcomes? According to a study published online Aug. 12 in Catheterization and Cardiovascular Outcomes, the answer is yes.

TCT.14: Stents and TAVR, keynote speakers highlighted

Bioresorbable stents, TAVR trials, and keynote speaker Hillary Clinton are high on the must-see list of presentations at this year’s Transcatheter Cardiovascular Therapeutics (TCT) conference, according to director Gregg W. Stone, MD. 

Did guidelines affect post-stent surgical outcomes?

The American College of Cardiology and the American Heart Association released guidelines in 2007 advising physicians to delay surgery following a cardiac stent placement. But, did they help reduce major adverse cardiac events (MACE) following these secondary surgeries? 

Early ticagrelor treatment safe but it doesn’t improve reperfusion

Administering an antiplatelet agent to patients with STEMI in an ambulance was safe but was no more effective at improving coronary reperfusion than treatment in the hospital, based on results from the ATLANTIC trial. Early administration may prevent stent thrombosis, though.

Biodegradable stent matches gold standard for safety, efficacy

A next-generation biodegradable drug-eluting stent proved noninferior to the standard of care in a randomized clinical trial that imposed minimal exclusion criteria, according to results published online Sept. 1 in The Lancet and simultaneously presented at the European Society of Cardiology meeting in Barcelona.

FAME 2, Act 2: FFR-guided PCI keeps its lead at 2 years

PCI guided by fractional flow reserve (FFR) in patients with stable coronary artery disease who were treated with second-generation drug-eluting stents and medical therapy reduced the need for urgent revascularization compared with medical therapy alone, according to two-year results from FAME 2.

Colchicine provides no sweeping benefit after cardiac surgery

Patients undergoing cardiac surgery had mixed results when using colchicine to reduce the incidence of postpericardiotomy syndrome, postoperative atrial fibrillation or postoperative pericardial or plural effusion, according to a study published online Aug. 30 in JAMA.

Trial patients may not reflect larger MI population

Participants enrolled in cardiovascular clinical trials may be a poor representation of patients with MI, according to an analysis published Aug. 27 in JAMA. Researchers found enrollees generally to be healthier, younger and have a better prognosis than eligible nonparticipants.

Hello? Operator? Cardiologists’ communication styles may confuse PCI patients

Joint PCI decision-making may be a best practice, but it appears physicians aren’t encouraging it through their communication styles, according to a paper published online Aug. 25 in JAMA: Internal Medicine.

Meta-analysis gives clarity to bivalirudin’s risk-benefit profile

Compared with heparin, bivalirudin increases the risk of major adverse cardiac events but reduces the risk of bleeding to varying degrees in patients undergoing PCI, a meta-analysis published in the Aug. 16 issue of The Lancet concluded.